Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo

Cancer Letters

Volumn 179, Issue 2, 2002, Pages 205-212

  Um, Soo Jong ^a   Rhyu, Jae Woong ^b   Kim, Eun Joo ^c   Jeon, Kook Che ^a   Hwang, Eun Seoung ^d   Park, Jong Sup ^c  

^a Sejong University   (South Korea)

^b Korean Institute of Radiological and Medical Sciences   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d University of Seoul   (South Korea)

Author keywords

Cervical cancer; Genes; Mice

Indexed keywords

BETA INTERFERON; INTERFERON REGULATORY FACTOR 1; MONOCYTE CHEMOTACTIC PROTEIN 1; TETRACYCLINE; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE TARGETING; HISTOPATHOLOGY; IMMUNOREGULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; TRANSGENIC MOUSE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DYSPLASIA; VIRUS EXPRESSION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; MUS MUSCULUS; PAPILLOMAVIRUS;

EID: 0037188431     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00871-0     Document Type: Article

References (35)

1. Human papillomavirus and genital cancer
2. Papillomavirus infections - A major cause of human cancers
3. Cellular transformation by papillomavirus oncoproteins
4. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation
5. Interaction of the E6 protein of human papillomavirus with cellular proteins
6. Telomerase activation by the E6 gene product of human papillomavirus type 16
7. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes
8. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein
9. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein
10. MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
11. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells
12. Analysis of MHC class I and II expression in relation to presence of HPV genetypes in premalignant and malignant cervical lesions
13. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumors
14. Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri
15. Monocyte-chemo-attractant-protein-1 (MCP-1)-gene expression in cervical intra-epithelial neoplasias and cervical carcinomas
16. Kinetically coordinated induction of TAP1 and HLA class I by IFN-γ: The rapid induction of TAP1 by IFN-γ is mediated by Stat1α
17. I.F.N. regulatory, factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo
18. Different requirements for signal transducer and activator of transcription 1α and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated antigen processing 1 gene expression
19. IFN-γ induction of human monocyte chemoattractant protein (hMCP-1) in astrocytoma cells: Functional interaction between an IFN-γ-activated site and a GC-rich element
20. A complex element regulates IFN-γ-stimulated monocyte chemoattractant protein-1 gene transcription
21. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity
22. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo
23. Regulation of type I interferon gene expression by interferon regulatory factor-3
24. E7-specific cytotoxic T cell tolerance in HPV-transgenic mice
25. The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-α
26. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
27. Identification and classification of p53-regulated genes
28. Presence of oncogenic HPV DNAs in cervical carcinoma tissues and pelvic lymph nodes associating with proliferating cell nuclear antigen expression
29. Detection of p16 gene deletions in cervical cancer using tissue microdissection and LOH study
30. Antiproliferative effects of retinoic acid/interferon in cervical carcinoma cell lines: Cooperative growth suppression of IRF-1 and p53
31. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis
32. Interferon regulatory factors: The next generation
33. Suppressor of c-myc or fosB-induced cell transformation by the transcription factor IRF-1
34. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1